Readout 360 with expert commentary and insights on new studies.
Recent Updates in the Role of Bispecifics in Multiple Myeloma: Highlights from ASH 2022 and Beyond
March 9th 2023Shaji Kumar, MD, Sandy Wong, MD, and Alexander Lesokhin, MD, review key data updates on the use of bispecific antibodies for the treatment of multiple myeloma presented at ASH 2022 and other recent meetings, and discuss how recent clinical trials have influenced treatment approaches in both the transplant-eligible and -ineligible patient populations.
Updates in the Treatment of Renal Cell Carcinoma: Highlights from IKCS and ESMO 2022
February 13th 2023A panel of experts review key data updates in renal cell carcinoma (RCC) from the International Kidney Cancer Association (IKCS) and European Society for Medical Oncology (ESMO) 2022 meetings and discuss how recent clinical trials are shaping the treatment of clear cell and non-clear cell RCC in clinical practice.